Investors
For all Investor inquiries, please contact info@pacificmarinebiotech.com.
News
PMB’s Primary Area of Focus
PMB’s focus is on launching clinical trials for GBM using its product, Immune12, a complex biologic compound derived from marine organisms.
August 20, 2025
Availability of Immune12
Investigational Product Immune12 is currently not available to the general public.
August 22, 2025